Taro Pharmaceuticals U.S.A., Inc. recalls Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay,
Recalled January 19, 2022 · FDA recall D-0375-2022 · Taro Pharmaceuticals U.S.A
Hazard
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria · FDA Class I
Units
96 tubes
Sold at
Two distributors in UT and LA who could have further distributed to the retail level nationwide in the USA.
Description
Microbial Contamination of Non-Sterile Products: presence of R. Pickettii bacteria
Product
Clobetasol Propionate Ointment USP, 0.05%, 60g tubes, Rx only, Mfd. by: Taro Pharmaceutical Industries Ltd., Haifa Bay, Israel 2624761, Dist. by: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532. NDC 51672-1259-3
Manufacturer(s)
Taro Pharmaceuticals U.S.A., Inc.
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →